Transgenic mice with a β4-integrin signaling domain mutation showed reduced prostate tumor formation and progression, thus supporting our data that ITGB4 is involved in tumor cell migration and metastasis [41]. The gene discussed is ITGB4; the disease is prostate neoplasm.